SNP Technology Focuses on Terror Victims' IDs

Graphic: Courtesy of Orchid Biosciences  SNP-based identifications are possible with fragments one-fourth the size needed for other methods. A well-lit, chrome-and-steel room hums as a robot uses multiple arms to carry 384-well plates from their platforms into readers, where an "SNPscope"--which has the capacity to read just a few pixels of fluorescence--captures data from the entire plate in six minutes and automatically transfers it to computer screens. A half-dozen researchers and ana

Written byLarry Hand
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

A well-lit, chrome-and-steel room hums as a robot uses multiple arms to carry 384-well plates from their platforms into readers, where an "SNPscope"--which has the capacity to read just a few pixels of fluorescence--captures data from the entire plate in six minutes and automatically transfers it to computer screens. A half-dozen researchers and analysts, led by Robert Giles, executive director of the identity genomics group at Orchid Cellmark's Dallas, Texas, laboratory, pore over the data. Their mission: Increase the odds of identifying remains of people killed in the Sept. 11, 2001 terrorist attack that brought down the World Trade Center towers in New York.

Orchid Cellmark, a business unit of Orchid BioSciences in Princeton, NJ, joined the massive forensics effort officially in August, after months of tests and trials passed muster with the review board overseeing the work managed by the New York City Medical Examiner's (ME) Office. That office's ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies